Volume 14, Number 5, November-December 2007

Scientific Sessions 2007 of the American Heart Association

Major new trials reported at the American Heart Association 2007 Scientific Sessions, held in Orlando, Florida, US, on November 3rd–7th, showed mixed results for the new antiplatelet agent, prasugrel, and gave renewed hope for the high-density lipoprotein raising field. But there was disappointment regarding the use of statins in heart failure and beta blockers in general surgery.

Br J Cardiol 2007;14:255-9.

View full PDF article (open in new window)
Email this article